AU2020904813A0 - SARS-CoV-2 antibodies - Google Patents

SARS-CoV-2 antibodies

Info

Publication number
AU2020904813A0
AU2020904813A0 AU2020904813A AU2020904813A AU2020904813A0 AU 2020904813 A0 AU2020904813 A0 AU 2020904813A0 AU 2020904813 A AU2020904813 A AU 2020904813A AU 2020904813 A AU2020904813 A AU 2020904813A AU 2020904813 A0 AU2020904813 A0 AU 2020904813A0
Authority
AU
Australia
Prior art keywords
cov
sars
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020904813A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Garvan Institute of Medical Research
Original Assignee
Garvan Institute of Medical Research
Filing date
Publication date
Application filed by Garvan Institute of Medical Research filed Critical Garvan Institute of Medical Research
Publication of AU2020904813A0 publication Critical patent/AU2020904813A0/en
Priority to CA3206295A priority Critical patent/CA3206295A1/en
Priority to PCT/AU2021/051550 priority patent/WO2022133545A1/en
Priority to US18/258,968 priority patent/US20240043506A1/en
Priority to EP21908157.7A priority patent/EP4267611A1/en
Priority to AU2021408144A priority patent/AU2021408144A1/en
Pending legal-status Critical Current

Links

AU2020904813A 2020-12-23 2020-12-23 SARS-CoV-2 antibodies Pending AU2020904813A0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA3206295A CA3206295A1 (en) 2020-12-23 2021-12-23 Sars-cov-2 antibodies
PCT/AU2021/051550 WO2022133545A1 (en) 2020-12-23 2021-12-23 Sars-cov-2 antibodies
US18/258,968 US20240043506A1 (en) 2020-12-23 2021-12-23 Sars-cov-2 antibodies
EP21908157.7A EP4267611A1 (en) 2020-12-23 2021-12-23 Sars-cov-2 antibodies
AU2021408144A AU2021408144A1 (en) 2020-12-23 2021-12-23 Sars-cov-2 antibodies

Publications (1)

Publication Number Publication Date
AU2020904813A0 true AU2020904813A0 (en) 2021-01-21

Family

ID=

Similar Documents

Publication Publication Date Title
EP3903817A4 (en) Novel anti-ccr8 antibody
EP3986936A4 (en) Anti-tigit antibodies
EP3820907A4 (en) Novel anti-cd39 antibodies
EP3918323A4 (en) Anti-gal3 antibodies and uses thereof
EP3784699A4 (en) Optimized anti-tl1a antibodies
EP3997127A4 (en) Dll3-targeting antibodies and uses thereof
EP3941944A4 (en) Claudin-6 bispecific antibodies
EP3752536A4 (en) Anti-her2 antibodies
EP3831851A4 (en) Anti-btla antibody
AU2019361253A1 (en) Anti-synuclein antibodies
EP3962954A4 (en) Anti-galectin-9 antibodies and uses thereof
EP3852779A4 (en) Anti-klrg1 antibodies
EP4025609A4 (en) Anti-steap1 antibodies and uses thereof
EP3986462A4 (en) Anti-tim-3 antibodies
EP3995582A4 (en) Anti-epha4 antibody
EP3737410A4 (en) Anti-siglec-7 antibodies having reduced effector function
EP3917965A4 (en) Novel anti-ifnar1 antibodies
EP4037703A4 (en) Anto-connexin antibody formulations
EP4010368A4 (en) Anti-nampt antibodies and uses thereof
EP3999115A4 (en) Novel bssl antibodies
EP3978015A4 (en) Bispecific antibody
EP3947462A4 (en) Anti-galectin-9 antibodies and uses thereof
EP3862366A4 (en) Cancer-stem-cell-specific antibody
EP3768725A4 (en) Novel anti-tim-3 antibodies
EP3766898A4 (en) Cadm1 v9-recognizing antibody